US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ampliphi Biosciences

4.45

0.0000

Volume:- -

Turnover:- -

Market Cap:148.96M

PE:-0.60

High:4.45

Open:4.45

Low:4.45

Close:4.45

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Ampliphi Biosciences

Exchange:

AMEX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.ampliphibio.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of various bacteriophage therapeutics. Its lead product candidate comprises AB-SA01 that is in Phase I clinical trial for the treatment of Staphylococcus aureus (S. aureus) infections, including methicillin-resistant S. aureus. The companys products under development include AB-PA01 for the treatment of Pseudomonas aeruginosa lung infections in cystic fibrosis patients; and AB-CD01 for the treatment of Clostridium difficile infections. It has a collaboration agreement with Intrexon Corporation to utilize synthetic biology platform for the identification, development, and production of bacteriophage-containing human therapeutics. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is based in San Diego, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/APHB/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APHB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APHB\",,,,,undefined,":{"symbol":"APHB","market":"US","secType":"STK","nameCN":"Ampliphi Biosciences","latestPrice":4.4506,"timestamp":1557431971292,"preClose":4.4506,"halted":8,"volume":0,"delay":0,"floatShares":32907498,"shares":33469008,"eps":-7.422054,"marketStatus":"Market Closed","change":0,"latestTime":"05-09 15:59:31 EDT","open":4.4506,"high":4.4506,"low":4.4506,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.422054,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1748332800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"ARMP","executeDate":"2019-05-10"},"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":4.4506,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APHB\",,,,,undefined,":{"symbol":"APHB","floatShares":32907498,"roa":"--","roe":"--","lyrEps":-0.638013,"shares":33469008,"dividePrice":0,"high":4.4506,"amplitude":0,"preClose":4.4506,"low":4.4506,"week52Low":2.1546,"pbRate":"30.03","week52High":19.1796,"institutionHeld":0,"latestPrice":4.4506,"eps":-7.422054,"divideRate":0,"volume":0,"delay":0,"ttmEps":-7.422054,"open":4.4506},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.ampliphibio.com","stockEarnings":[{"period":"1week","weight":-0.9286},{"period":"1month","weight":-0.9286},{"period":"3month","weight":-0.9286},{"period":"6month","weight":-0.9286},{"period":"1year","weight":-0.9286},{"period":"ytd","weight":-0.9286}],"compareEarnings":[{"period":"1week","weight":-0.0254},{"period":"1month","weight":0.0816},{"period":"3month","weight":-0.0347},{"period":"6month","weight":-0.0275},{"period":"1year","weight":0.1011},{"period":"ytd","weight":-0.0119}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of various bacteriophage therapeutics. Its lead product candidate comprises AB-SA01 that is in Phase I clinical trial for the treatment of Staphylococcus aureus (S. aureus) infections, including methicillin-resistant S. aureus. The companys products under development include AB-PA01 for the treatment of Pseudomonas aeruginosa lung infections in cystic fibrosis patients; and AB-CD01 for the treatment of Clostridium difficile infections. It has a collaboration agreement with Intrexon Corporation to utilize synthetic biology platform for the identification, development, and production of bacteriophage-containing human therapeutics. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is based in San Diego, California.","exchange":"AMEX","name":"Ampliphi Biosciences","nameEN":"Ampliphi Biosciences"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"APHB\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APHB\",params:#limit:5,,,undefined,":[{"date":"2019-11-06","symbol":"APHB","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1573074000000,"name":null,"time":"Post Market","dateTimestamp":1573016400000,"actualEps":null},{"market":"US","date":"2019-08-07","symbol":"APHB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1565150400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-05-10","symbol":"APHB","type":"split","dateTimestamp":1557460800000,"forFactor":14,"toFactor":1,"ratio":14},{"market":"US","date":"2019-05-06","symbol":"APHB","fiscalQuarterEnding":"2019/03","expectedEps":-0.11,"name":null,"time":"","type":"earning","dateTimestamp":1557115200000,"reportTimeType":"","actualEps":-0.11},{"market":"US","date":"2019-03-25","symbol":"APHB","fiscalQuarterEnding":"2018/12","expectedEps":-0.08,"name":null,"time":"","type":"earning","dateTimestamp":1553486400000,"reportTimeType":"","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APHB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APHB\",market:\"US\",delay:false,,,undefined,":{}}}